Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-06-04

Clinical Trial Update: PLAsticity, Security and Tolerance to Intermittent Hypoxic Conditioning Following Stroke [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating intermittent hypoxic conditioning to enhance neural plasticity after ischemic stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Stroke, Ischemic, Stroke Sequelae | Phase 1, Phase 2 | Status: WITHDRAWN